百日咳疫苗市場規模、佔有率和成長分析：按產品類型、疫苗類型、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球百日咳疫苗市場價值為 50.7 億美元，預計到 2025 年將成長至 52.6 億美元，到 2033 年將成長至 70.9 億美元，在預測期（2026-2033 年）內複合年成長率為 3.8%。

由於各國法規結構的協調統一，全球百日咳疫苗市場預計將顯著成長。這一趨勢將加速疫苗生產商進入市場，降低研發成本，並增加對候選疫苗的投資。主要監管機構簡化核准流程，提升了無細胞製劑的吸引力，新興市場生物技術公司與疫苗生產商之間的策略合作就是例證。此類合作不僅擴大了高風險族群的接種管道，也創造了穩定的收入來源，增強了產業的韌性，並加速了研發進程。最終，這將推動市場成長，並改善全球公共衛生狀況。

全球百日咳疫苗市場成長要素

全球百日咳疫苗市場正經歷顯著成長，這主要得益於大眾對百日咳（尤其是新生兒）嚴重併發症認知的不斷提高。隨著醫療保健宣傳活動和媒體報告的增多，家長和醫護人員越來越重視疫苗接種。對安全有效百日咳疫苗的需求促使生產商提高產能並研發新的配方。隨著整個免疫體系的普及，一種良性循環正在形成，促進了各個地區的成長，並有助於改善公共衛生狀況和實現永續的疾病控制。

全球百日咳疫苗市場的限制因素

全球百日咳疫苗市場受到許多因素的限制，包括對百日咳疫苗的誤解，以及部分家長群體對疫苗安全性的持續擔憂。這些擔憂導致疫苗接種計劃延誤甚至出現拒絕接種的情況，最終降低了整體市場需求。對疫苗缺乏信心阻礙了新產品研發的投資，也影響了旨在控制疾病的醫療保健措施的成效。因此，製造商面臨著難以預測的銷售模式，而醫療系統則被迫將更多資源投入到宣傳宣傳活動中，這進一步抑制了市場成長。這種不確定性也使分銷網路的長期規劃變得複雜，迫使企業根據區域疫苗接種率的波動調整庫存策略。

全球百日咳疫苗市場趨勢

全球百日咳疫苗市場正呈現出加強成人免疫接種計畫的顯著趨勢，這主要得益於人們對老年人群中百日咳疫情復燃的日益關注。流行病學數據顯示，老年族群免疫力下降，重症病例增加，尤其是在孕婦和老年人等弱勢群體中，促使各國政府將百日咳加強疫苗接種納入青少年和成人免疫接種計畫。公共衛生部門致力於彌合免疫缺口、促進群體免疫並刺激對新一代疫苗製劑的需求，透過將百日咳疫苗接種有效整合到成人常規體檢和職場健康促進計劃中，正在擴大市場規模。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球百日咳疫苗市場規模：依產品類型分類

• 白喉疫苗（DTaP）
• 破傷風
• 無細胞型（百日咳）
• Tdap（破傷風）
• 白喉
• 百日咳 - 成人加強針
• 全細胞百日咳疫苗（wP）
• 聯合疫苗（含百日咳抗原）

全球百日咳疫苗市場規模：依疫苗類型分類

• 無細胞百日咳疫苗（aP）
• 全細胞百日咳疫苗（wP）

全球百日咳疫苗市場規模：依應用領域分類

• 兒童疫苗接種
• 青少年加強免疫接種
• 成人加強針
• 孕婦疫苗接種

全球百日咳疫苗市場規模：依最終用戶分類

• 醫院和診所
• 政府免疫計劃
• 私立醫療機構

全球百日咳疫苗市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Pfizer Inc.
• Merck & Co. Inc.
• GlaxoSmithKline plc
• Sanofi Pasteur SA
• CSL Limited
• Serum Institute of India Pvt. Ltd.
• Biological E. Limited
• Bharat Biotech International Ltd.
• Panacea Biotec Limited
• PT Bio Farma
• Walvax Biotechnology Co. Ltd.
• Hualan Biological Engineering Inc.
• Shenzhen Kangtai Biological Products
• Wuhan Institute of Biological Products
• Chongqing Zhifei Biological Products
• Mitsubishi Tanabe Pharma
• Emergent BioSolutions Inc.
• Bavarian Nordic A/S
• BioNTech SE
• Valneva SE

結論與建議

Global Pertussis Vaccine Market size was valued at USD 5.07 Billion in 2024 and is poised to grow from USD 5.26 Billion in 2025 to USD 7.09 Billion by 2033, growing at a CAGR of 3.8% during the forecast period (2026-2033).

The global pertussis vaccine market is poised for significant growth due to the harmonization of regulatory frameworks across various economies. This trend facilitates quicker market entry and reduces development costs for manufacturers, resulting in higher investments in vaccine candidates. Streamlined approval processes by key regulatory bodies enhance the attractiveness of acellular formulations, exemplified by strategic partnerships between biotech firms and vaccine manufacturers in emerging markets. Such collaborations not only expand access to at-risk populations but also create robust revenue streams that support resilience and foster research and development initiatives within the sector, ultimately driving the market forward and improving public health outcomes worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pertussis Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pertussis Vaccine Market Segments Analysis

Global pertussis vaccine market is segmented by product type, vaccine type, application, end user and region. Based on product type, the market is segmented into DTaP (diphtheria, tetanus, acellular pertussis), Tdap (tetanus, diphtheria, pertussis (adult booster)), whole-cell pertussis vaccines (wP) and combination vaccines (including pertussis antigen). Based on vaccine type, the market is segmented into acellular pertussis (aP) and whole-cell pertussis (wP). Based on application, the market is segmented into pediatric immunization, adolescent booster, adult booster and maternal immunization. Based on end user, the market is segmented into hospitals & clinics, government immunization programs and private healthcare facilities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pertussis Vaccine Market

The Global Pertussis Vaccine market is experiencing significant growth driven by heightened public awareness of the severe complications associated with pertussis, especially among newborns. As health campaigns and media reports shed light on this issue, both parents and healthcare providers are becoming increasingly focused on ensuring vaccinations are administered. This demand for safe and effective pertussis vaccines is encouraging manufacturers to enhance their production capabilities and innovate new formulations. As the overall immunization framework gains broader acceptance, this creates a positive feedback loop, facilitating growth across various regions and enabling improved public health outcomes and sustained disease control initiatives.

Restraints in the Global Pertussis Vaccine Market

The global market for pertussis vaccines is hindered by ongoing concerns among certain caregiver groups regarding vaccine safety, coupled with misconceptions surrounding pertussis immunization. These apprehensions result in delays or outright refusals in vaccination schedules, ultimately diminishing overall market demand. The lack of confidence in vaccines discourages investment in new product development and hampers the success of public health initiatives aimed at controlling the disease. Consequently, manufacturers encounter unpredictable sales patterns, while healthcare systems must allocate additional resources for educational campaigns, stifling market growth. This uncertainty also complicates long-term planning for distribution networks, requiring companies to adjust their inventory strategies based on varying regional uptake.

Market Trends of the Global Pertussis Vaccine Market

The Global Pertussis Vaccine market is witnessing a notable trend towards enhanced adult immunization programs, driven by a growing recognition of the disease's resurgence among older populations. Governments are increasingly incorporating pertussis boosters into vaccination schedules for teens and adults, spurred by alarming epidemiological data indicating diminishing immunity and a rise in severe cases, particularly in vulnerable groups like pregnant women and the elderly. Public health initiatives aim to bridge immunity gaps, promote herd protection, and stimulate demand for next-generation vaccine formulations, effectively embedding pertussis vaccinations within routine adult health visits and workplace health initiatives, thereby broadening the market landscape.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Pertussis Vaccine Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• DTaP (Diphtheria)
• Tetanus
• Acellular (Pertussis)
• Tdap (Tetanus)
• Diphtheria
• Pertussis - Adult Booster
• Whole-Cell Pertussis Vaccines (wP)
• Combination Vaccines (including Pertussis antigen)

Global Pertussis Vaccine Market Size by Vaccine Type & CAGR (2026-2033)

• Market Overview
• Acellular Pertussis (aP)
• Whole-Cell Pertussis (wP)

Global Pertussis Vaccine Market Size by Application & CAGR (2026-2033)

• Market Overview
• Pediatric Immunization
• Adolescent Booster
• Adult Booster
• Maternal Immunization

Global Pertussis Vaccine Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Government Immunization Programs
• Private Healthcare Facilities

Global Pertussis Vaccine Market Size & CAGR (2026-2033)

• North America (Product Type, Vaccine Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Vaccine Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Vaccine Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Vaccine Type, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Vaccine Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Pasteur SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biological E. Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech International Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panacea Biotec Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PT Bio Farma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Walvax Biotechnology Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hualan Biological Engineering Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Kangtai Biological Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuhan Institute of Biological Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chongqing Zhifei Biological Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsubishi Tanabe Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bavarian Nordic A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioNTech SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valneva SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations